Patent · US Active

Cytarabine monophosphate prodrugs

US7553826B2 · kind B2 · utility

11Cited by
58References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 18, 2006
Grant dateJun 30, 2009
Priority date
Expiry dateOct 18, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07H19/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of Formula I, their preparation and uses are described:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.